United Therapeutics CEO Martine A. Rothblatt reports $5.63 million common-share disposal
UTHR•United Therapeutics CEO Martine A. Rothblatt sold 9,500 common shares held through trusts on November 13, 2026, and exercised 9,500 stock options at $117.76 per share. The affected trusts held 324,443 shares after the transactions, while Rothblatt separately held 40,513 shares directly.
1. Share transactions
Rothblatt sold 9,500 common shares held through trusts and exercised 9,500 stock options at $117.76 per share on November 13, 2026. Afterward, the affected trusts held 324,443 common shares; Rothblatt separately held 40,513 shares directly.




